Q1'23 report due on Tuesday, 9 May Revised oil price assumptions Reiterate fair value range of SEK 6...
The subscription rate of 31% is below average. However, thanks to the use of a top guarantee, 100% ...
Redeye updates on Evolution post Q1-results which came in somewhat above our expectations driven by ...
Redeye thinks the Q1 report was weak, but in line with Redeye's expectations.
Redeye gives an updated view on Gapwaves after its Q1'23 report.
Redeye comments on Gasporox Q1'23 report which beat expectations across the board.
Redeye provides an update in relation to Enzymatica’s Q1 2023 report.
Redeye takes a positive stance towards Hexatronic following a solid Q1 and a sharp share price decli...
Redeye will likely leave its Base Case and forecasts roughly unchanged following Vertiseit’s Q1 repo...
Redeye reiterates its fair value range following a deeper dive into the Q1 report.
Blick Global publicerade den 27 april år 2023 bolagets delårsrapport för det första kvartalet 2023.
Redeye retains its positive view of Hexatronic following a solid Q1 report, with EBITA beating our f...
Brittiska förvärvet fortsätter kompensera för vikande nordisk marknad.
Q1 numbers softer, but it's a small quarter We push our market recovery assumptions back 11x '23e EV...
Stark trend i ARR-tillväxt bruten Omsättningen i kvartalet uppgick till 36,2 mkr vilket motsvarar en...
Q1 tyngdes av kostnader för att hantera kommande tillväxt och dåligt väder i US Ökade konsultkostnad...
3% sales miss, but better underlying profits than expected '23e-'25e EBIT down 12-5% on lower sales ...
Production stop in F&MT affects Q1 Decommissioning a bright spot Report in line with ABGSCe when adj...
IAR Systems’ Q1 results were soft and missed our adj.
Detection Technology’s Q1 topline came in as expected.
